Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > We have been challenged
View:
Comment by SouthernTierTom on Aug 18, 2021 3:29pm
My video player is broken, but I assume the content relates to the difficulties around starting a human trial?
Comment by DavidKingCanada on Aug 18, 2021 4:41pm
RC, sometimes I think you are a automatic Bot setup to deliver News that is not very well related. Keep chumming bud! 
Comment by JackRedwood on Aug 18, 2021 4:44pm
RetiredCop is supposedly an undercover Insider for Arfxf? LOL yeah sure bud! 
Comment by Speyeder999 on Aug 18, 2021 5:00pm
Thanks for the the link RC.  I consult the Cure Alzheimers Funds regularly seeing how Rudy Tanzi is chair of our SAB.
Comment by Gbathat on Aug 18, 2021 7:31pm
Great video RC. Thanks for sharing. I think Dr. Cashman is up for the challenge and has a great approach.  Cheers.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities